stella
beta
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy — Stella
Recruiting
Back to Parkinson Disease trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(1 site)
United States
UAB Advanced Imaging Facility, Birmingham, Alabama
View full record on ClinicalTrials.gov